Mr. Michael Bates is an Angel Investor. Mr. Bates served as Director at Dextera Surgical. Mr. Bates served as Board Member at Deep Blue Medical Advances. He was an Advisor of ShareVault. He also is an Angel Investor. Bates serves as an Advisor at Pandesa. Most recently, he was Chief Financial Officer for St. Francis Medical Technologies, acquired by Kyphon Inc. in January 2007 for approximately $725 million. In addition to the St. Francis success, he has contributed to successful investor outcomes in his three previous companies. He served as Vice President of Finance and Administration and CFO for Silicon Genetics, acquired by Agilent Technologies; Collagen Aesthetics, Inc., acquired by Inamed Corporation; and Penederm Incorporated, a publicly-traded specialty pharmaceutical company, acquired by Mylan Laboratories. He is a certified public accountant, having begun his career at Deloitte and Touche LLP. He is a graduate of California State University at Hayward and received an MBA in Finance from the University of California at Berkeley.